Sei Investments CO Editas Medicine, Inc. Transaction History

Sei Investments CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$31.29 - $56.64 $731,935 - $1.32 Million	-23,392 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$27.07 - $84.35 $633,221 - $1.97 Million	23,392 New	23,392 $1.63 Million
Q2 2019 Aug 14, 2019	SELL	$20.48 - $27.76 $852,480 - $1.16 Million	-41,625 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$19.43 - $26.41 $808,773 - $1.1 Million	41,625 New	41,625 $1.05 Million
Q3 2018 Nov 08, 2018	SELL	$27.65 - $38.39 $22,120 - $30,712	-800 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$31.4 - $41.01 $51,810 - $67,666	-1,650 Reduced 67.35%	800 $29,000
Q1 2018 May 11, 2018	BUY	$29.84 - $44.08 $73,108 - $107,996	2,450 New	2,450 $82,000

250

57.1M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $92.1M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.